发明申请
US20110293746A1 Modulation of Gsk-3Beta and Method of Treating Proliferative Disorders
审中-公开
Gsk-3Beta的调节和治疗增生性疾病的方法
- 专利标题: Modulation of Gsk-3Beta and Method of Treating Proliferative Disorders
- 专利标题(中): Gsk-3Beta的调节和治疗增生性疾病的方法
-
申请号: US11631751申请日: 2005-07-08
-
公开(公告)号: US20110293746A1公开(公告)日: 2011-12-01
- 发明人: Qiang Yu
- 申请人: Qiang Yu
- 专利权人: Agency For Science, Technology and Research
- 当前专利权人: Agency For Science, Technology and Research
- 国际申请: PCT/SG05/00223 WO 20050708
- 主分类号: A61K33/14
- IPC分类号: A61K33/14 ; A61K31/7048 ; A61K31/505 ; A61P35/00 ; G01N33/573 ; A61K31/436 ; A61K31/36
摘要:
There is provided methods and uses for promoting cell death, when combined with chemotherapeutic agents, in an abnormally proliferating cell, and for treating a proliferative disorder in a subject, which methods and uses involve contacting a cell with, or administering to a subject, an agent that modulates glycogen synthase kinase-3β activity to a cell that is being treated with a chemotherapeutic agent.